LifeCycle Pharma Announces Appointment of New Chief Financial Officer

H0RSHOLM, Denmark--(BUSINESS WIRE)--LifeCycle Pharma A/S (OMX: LCP), an emerging specialty pharmaceutical company, announced today that it has appointed Hans Christian Teisen as Senior Vice President and CFO to replace Michael Wolff Jensen, Executive Vice President and CFO, who has decided to leave the company, effective March 2008.

MORE ON THIS TOPIC